This study is funded by the National Institute for Health Research NIHR Bristol Biomedical Research Centre (Nutrition theme) at University Hospitals Bristol NHS Foundation Trust and The University of Bristol.Peer reviewedPublisher PD
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Background: Cardiovascular disease (CVD) causes 19% of all deaths in New Zealand; the contribution o...
Familial hypercholesterolaemia (FH) is a genetic condition characterised by elevated levels of low-d...
Background Untreated heterozygous familial hypercholesterolaemia (FH) causes high low-density lipop...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
Background. Because of a high cardiovascular disease (CVD) risk in people with Familial Hypercholest...
Abstract Background Because of a high cardiovascular disease (CVD) risk in people with Familial Hype...
Background: More insight in the association between reach, dose and fidelity of intervention compone...
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Background: Cardiovascular disease (CVD) causes 19% of all deaths in New Zealand; the contribution o...
Familial hypercholesterolaemia (FH) is a genetic condition characterised by elevated levels of low-d...
Background Untreated heterozygous familial hypercholesterolaemia (FH) causes high low-density lipop...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
Objective Familial hypercholesterolaemia (FH) elevates low-density lipoprotein cholesterol (LDL-C) a...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, ...
Background. Because of a high cardiovascular disease (CVD) risk in people with Familial Hypercholest...
Abstract Background Because of a high cardiovascular disease (CVD) risk in people with Familial Hype...
Background: More insight in the association between reach, dose and fidelity of intervention compone...
Lifestyle modification is a pivotal intervention for Familial Hypercholesterolaemia (FH). This study...
Abstract Background More insight in the association between reach, dose and fidelity of intervention...
Background: Cardiovascular disease (CVD) causes 19% of all deaths in New Zealand; the contribution o...